NCT07100353

Brief Summary

This study tracks the long-term development of premature infants to examine how birth profiles, risk factors, and physical functioning influence their activities, participation, and quality of life. It also identifies predictors of functional outcomes, evaluates assessment tool sensitivity, validates the General Movements Assessment (GMA) as a prognostic tool, and compares findings with the Taiwan Infant Development Database. The study hypothesizes that birth conditions and postnatal complications predict differences in development and well-being, that risk factors and physical function relate to participation and quality of life, and that the GMA will show reliable validity across disability categories.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for all trials

Timeline
5mo left

Started Oct 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Oct 2023Sep 2026

Study Start

First participant enrolled

October 1, 2023

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

July 28, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 3, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2026

Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

3 years

First QC Date

July 28, 2025

Last Update Submit

July 28, 2025

Conditions

Keywords

Developmental FunctionDaily LivingParticipationQuality of Life

Outcome Measures

Primary Outcomes (5)

  • Bayley scales of infant and Toddler Development- fourth edition, Bailey-IV

    Baseline

  • Comprehensive Development Inventory for Infant and Toddlers (CDIIT)

    Baseline

  • KIT Development and Health Questionnaire

    Baseline

  • General Movements Assessment (GMA)

    Baseline

  • PREMature Infant Index (PREMII)

    Baseline

Study Arms (2)

Full-term Children

This study will recruit 100 full-term children (ages 0-3) without neurological or developmental disorders for longitudinal follow-up.

Premature Children

This study will recruit 350 pretmature children (born \<37 weeks, ages 0-3) in stable treatment for longitudinal follow-up.

Eligibility Criteria

Age0 Years - 3 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

This study will recruit 100 full-term children and 350 premature children for a longitudinal follow-up.

You may qualify if:

  • Born before 37 weeks.
  • Aged 0-3 years.
  • Caregivers consent and agree to cooperate.
  • Stable condition with regular outpatient care, medication, and rehabilitation.

You may not qualify if:

  • Acute illness (e.g., infection).
  • Parents/caregivers unable to communicate in Chinese.
  • \. Full-term Cases
  • Born at full term.
  • Aged 0-3 years.
  • No disease affecting neurophysiological development.
  • Caregivers consent and agree to cooperate.
  • Medical conditions affecting neurophysiological development (e.g., traumatic brain injury).
  • Neurodevelopmental disorders
  • Sensory perception disorders
  • Chromosomal abnormalities
  • Parents/caregivers unable to communicate in Chinese.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung Memorial Hospital

Taoyuan District, 333, Taiwan

Location

Biospecimen

Retention: SAMPLES WITH DNA

Samples with DNA

MeSH Terms

Conditions

Premature Birth

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Chia-Ling Chen

    Chang Gung Memorial Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2025

First Posted

August 3, 2025

Study Start

October 1, 2023

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2026

Last Updated

August 3, 2025

Record last verified: 2025-07

Locations